编译自:Michael O'Riordan。New NICE Guidelines Recommend Lower Risk Threshold for Starting Statins. Heartwire.July 18, 2014 指南推荐摘要: 一、心血管疾病风险评估 1.年龄≤84岁的一般人群可使用QRISK2风险评估计算器评估10年心血管疾病风险。 2.部分特定人群不适用现行的风险评估计算器,需要特别注意的是以下...
[28]SchadeDS,DuroT,EatonRP.OptimalPrescribingofStatins toReduceCardiovascularDisease[J].AmJMed,2023,136(12):1 133-1135.DOI:10.1016/j.amjmed,2023.06.030. [29]MachF,BaigentC,CatapanoAL,etal.2019ESC/EASGuidelines forthemanagementofdyslipidaemias:lipidmodificationtoreduceca rdiovascularrisk:TheTaskForce...
1.3Lifestylechangesfortheprimaryandsecondarypreventionofcardiovasculardisease10 1.4Initiallipidmeasurementandreferralforspecialistreview13 1.5Discussionsandassessmentbeforestartingstatins14 1.6Statinsforprimarypreventionofcardiovasculardisease17 1.7Lipid-loweringtreatmentforsecondarypreventionofcardiovasculardisease19 ...
The advice is that for primary prevention, GPs should use atorvastatin 20mg, while for secondary prevention, atorvastatin 80mg is preferred. New recommendations Statins are now recommended for patients with type 1 diabetes, with no lower age limit specified, which is surprisin...
It has been clearly established that lipid-lowering treatments [such as 3-hydroxyl-3-methylglutamyl coenzyme A reductase inhibitors ('statins') or fibrates... B Tomlinson,P Chan,L Wei - 《Drugs & Aging》 被引量: 59发表: 2001年 How does lipid lowering prevent coronary events? New insights ...
Statin therapy for the primary prevention of cardiovascular disease(CVD)has been recommended by the National Institute for Health and Clinical Excellence for adults who have a 20 per cent or greater 10-year risk of developing CVD.Guidance published this week also recommends statins for adults with ...
The new guidance means up to 4.5 million NHS patients could eligible to take statins to lower cholesterol in the blood and reduce the risk of heart attack and stroke. Extra statin use would drastically benefit both the economy and society, according to NICE, with one in three deaths attributed...
Anupdate of existing National Institute for Health and CareExcellence (NICE) guidance (published in 2008)1 was necessaryin light of new evidence on the efficacy and safety of statintherapy,2on the effects of combining statins with non-statindrugs,3-5and on novel risk assessment tools for ...
Topics discussed include the use of QRISK2 as cardiovascular risk assessment to prevent cardiovascular disease (CVD), the division of the statin drugs and dosages into low, medium, and high-intensity, and the use of atorvastatin to initiate statins....
NICE sticks to its advice to drop threshold for prescribing statins The group responsible for recommending the wider use of statins had faced "completely unjustified attacks on their integrity," the director of the Centre f... N Hawkes - Bmj 被引量: 11发表: 2014年 加载更多研究...